Updates in Neonatal Seizures
- PMID: 40350217
- DOI: 10.1016/j.clp.2025.02.008
Updates in Neonatal Seizures
Abstract
Neonatal seizures are a common medical emergency, necessitating prompt treatment. The most common etiologies include hypoxic-ischemic encephalopathy, ischemic stroke, and intracranial hemorrhage, with numerous other uncommon etiologies. Accurate diagnosis requires conventional video-electroencephalogram (cvEEG) to distinguish seizures from nonepileptic movements and to detect electrographic-only (subclinical) seizures. Treatment prioritizes rapid medication administration, with phenobarbital as first-line treatment and the only Federal Drug Administration (FDA)-approved medication for neonatal seizures. Prognosis depends on seizure etiology and severity. Advances in artificial intelligence show promise for improved seizure detection and prognostication. Further research and randomized controlled trials of novel medications are needed.
Keywords: Antiseizure medications; EEG; Epilepsy; Neonates; Seizures.
Copyright © 2025 Elsevier Inc. All rights reserved.
Conflict of interest statement
Disclosure Dr J.V. Gettings receives research funding from NIH. Dr J. Soul conducted an investigator-initiated research study of lacosamide with funding from UCB, Belgium that ended in December 2022.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical